Literature DB >> 20827409

Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units.

João Galizzi F, Rosângela Teixeira, José C F Fonseca, Francisco J D Souto.   

Abstract

PURPOSE: To assess data about chronic forms of hepatitis B virus (HBV) infection in Brazilian reference units, the Brazilian Society of Hepatology (SBH) performed a survey, with its associates spread throughout the country.
METHODS: SBH members were contacted by electronic mail. They were asked for data from their liver units regarding chronically infected HBV patients between January 2005 and September 2007. All subjects with HBV surface antigenemia lasting more than 6 months were eligible. Patients who died after January 2005 were also included.
RESULTS: Data from 24 units of 17 cities (12 Brazilian states) were obtained. These corresponded to 3,913 patients. Mean age was 39 years, ranging from 1 to 84 years. The northern region had the lowest mean age (35 years) and the southern region the highest (43 years). Most of the sampled people were white; 1,448 of 3,614 patients had chronic hepatitis B. Most of them were HBeAg negative (1.4:1). There were 1,695 (46.9%) inactive carriers of 3,614 HBV-infected patients and other 69 (1.9%) were considered as having immune-tolerant status. Hepatitis D coinfection was common among the Amazonian sample (n = 369).
CONCLUSIONS: This large sample study shows important tendencies of chronic hepatitis B infection in Brazilian reference units, such as HBeAg-negative chronic hepatitis B cases overwhelming wild-type strains infected cases. Besides, hepatitis D occurs only among the Amazonian patients.

Entities:  

Keywords:  Bloodborne infection; Brazil; Chronic hepatitis; Hepatitis B virus; South America

Year:  2010        PMID: 20827409      PMCID: PMC2900552          DOI: 10.1007/s12072-010-9178-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  14 in total

Review 1.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  [Hepatitis B and C serologic markers in blood donors of the Ribeirão Preto Blood Center].

Authors:  Vanderléia Bárbaro Valente; Dimas Tadeu Covas; Afonso Dinis Costa Passos
Journal:  Rev Soc Bras Med Trop       Date:  2006-01-04       Impact factor: 1.581

Review 3.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

Review 4.  Natural history and prognosis of hepatitis B.

Authors:  Giovanna Fattovich
Journal:  Semin Liver Dis       Date:  2003-02       Impact factor: 6.115

5.  Distribution of hepatitis B virus genotypes among patients with chronic infection.

Authors:  Nadia Regina Caldas Ribeiro; Gubio Soares Campos; Ana Luiza Dias Angelo; Eduardo Lorens Braga; Nelma Santana; Michele Mesquita Soares Gomes; Joao Renato Rebello Pinho; Wilson Andrade De Carvalho; Luiz Guilherme Costa Lyra; Andre Castro Lyra
Journal:  Liver Int       Date:  2006-08       Impact factor: 5.828

6.  Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin.

Authors:  Michele Soares Gomes-Gouvêa; Manoel do Carmo Pereira Soares; Isabel Maria Vicente Guedes de Carvalho Mello; Elisabete Maria Figueiredo Brito; Lizomar de Jesus Maués Pereira Moia; Gilberta Bensabath; Heloisa Marceliano Nunes; Flair José Carrilho; João Renato Rebello Pinho
Journal:  Acta Trop       Date:  2008-03-18       Impact factor: 3.112

7.  Hepatitis B virus genotypes and precore and core mutants in Brazilian patients.

Authors:  Roberta Sitnik; João Renato Rebello Pinho; Dennis Armando Bertolini; Antonio Plinio Bernardini; Luiz Caetano Da Silva; Flair José Carrilho
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

8.  Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years.

Authors:  Mauro Manno; Calogero Cammà; Filippo Schepis; Fabio Bassi; Roberta Gelmini; Francesco Giannini; Francesca Miselli; Antonella Grottola; Ilva Ferretti; Chiara Vecchi; Marisa De Palma; Erica Villa
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

Review 9.  Hepatitis B virus: inactive carriers.

Authors:  Sanjeev Kumar Sharma; Nitin Saini; Yogesh Chwla
Journal:  Virol J       Date:  2005-09-28       Impact factor: 4.099

10.  Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil.

Authors:  Marcelle Bottecchia; Francisco J D Souto; Kycia M R O; Marcia Amendola; Carlos E Brandão; Christian Niel; Selma A Gomes
Journal:  BMC Microbiol       Date:  2008-01-22       Impact factor: 3.605

View more
  4 in total

1.  Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B.

Authors:  Sidelcina Rugieri Pacheco; Maria Isabel Magalhães Andrade Dos Santos; Andreas Stocker; Maria Alice Sant'Anna Zarife; Maria Isabel Schinoni; Raymundo Paraná; Mitermayer Galvão Dos Reis; Luciano Kalabric Silva
Journal:  Infect Drug Resist       Date:  2017-07-05       Impact factor: 4.003

2.  Characteristics of an outpatient chronic hepatitis B virus infection cohort.

Authors:  Danyenne Rejane de Assis; Simone de Barros Tenore; João Renato Rebello Pinho; David Salomão Lewi; Paulo Roberto Abrão Ferreira
Journal:  Einstein (Sao Paulo)       Date:  2015 Apr-Jun

3.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14

4.  Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors.

Authors:  Marlone Cunha-Silva; Fábio R T Marinho; Paulo F Oliveira; Tirzah M Lopes; Tiago Sevá-Pereira; Sonia L S Lorena; Jazon R S Almeida
Journal:  Braz J Infect Dis       Date:  2017-05-26       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.